Vivan Therapeutics
PrivateLast Round
VC Round
Nov 3, 2025
Total Funding Raised
$5.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vivan Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in November 2025.
Vivan Therapeutics is a biotechnology company that provides a personalized cancer therapeutics platform utilizing fruit fly avatars and AI to test drug combinations and recommend treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivan Therapeutics Comparables
Compare Vivan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Travera | 84% | |
| Xilis | 83% | |
| SageMedic Corp. | 79% |
For institutional investors. Book with your work email.
Vivan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 3, 2025 | ||||
| Grant | May 1, 2021 |
For institutional investors. Book with your work email.
Vivan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granatus Ventures | Seed |
| Freya Ventures | Seed |
| Innovate UK | Grant |
| Reflect Ventures | Seed |
| Hub71 | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 43% MoM.
- Nov 3, 2025
Raised $5M from Hub71.
For institutional investors. Book with your work email.
Vivan Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivan Therapeutics's valuation, stock price, and market status.
Is Vivan Therapeutics a public or private company?
Vivan Therapeutics is a private company.
What is the current stock price of Vivan Therapeutics?
Vivan Therapeutics is a private company, so its shares have no public market price. Caplight tracks Vivan Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivan Therapeutics worth (valuation)?
Valuation information for Vivan Therapeutics is not publicly available.
Can I buy Vivan Therapeutics stock?
Vivan Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivan Therapeutics's last funding round?
Vivan Therapeutics's most recent funding round was VC Round on November 3, 2025.
Who are the main investors in Vivan Therapeutics?
Key investors in Vivan Therapeutics include Granatus Ventures, Freya Ventures, Innovate UK, Reflect Ventures, Hub71.
Will Vivan Therapeutics IPO soon?
No public IPO plans have been announced for Vivan Therapeutics.
How can I track Vivan Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Vivan Therapeutics's shares on secondary markets.